Literature DB >> 21703168

A major step towards effective treatment evaluation in primary biliary cirrhosis.

Ulrich Beuers, Keith D Lindor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21703168     DOI： 10.1016/j.jhep.2011.04.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study.

Authors:  Jiangyi Zhu; Yongquan Shi; Xinmin Zhou; Zengshan Li; Xiaofeng Huang; Zheyi Han; Jianhong Wang; Ruian Wang; Jie Ding; Kaichun Wu; Ying Han; Daiming Fan
Journal:  Front Med       Date:  2012-11-23       Impact factor: 4.592

2.  Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.

Authors:  Mehmet Sayiner; Maria Stepanova; Leyla De Avila; Pegah Golabi; Andrei Racila; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-08-27       Impact factor: 3.199

3.  Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years.

Authors:  Kirsten Boonstra; Robin Bokelaar; Paul H Stadhouders; Hans A Tuynman; Alexander C Poen; Karin M van Nieuwkerk; Ellen M Witteman; Dörte Hamann; Ben J Witteman; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  Hepatol Int       Date:  2014-03-28       Impact factor: 6.047

Review 4.  Proposed therapies in primary biliary cholangitis.

Authors:  Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-01-06       Impact factor: 3.869

5.  The association between bile salt export pump single-nucleotide polymorphisms and primary biliary cirrhosis susceptibility and ursodeoxycholic acid response.

Authors:  Rui-rui Chen; Yuan-jun Li; Xin-min Zhou; Lu Wang; Juan Xing; Shuang Han; Li-na Cui; Lin-hua Zheng; Kai-chun Wu; Yong-quan Shi; Zhe-yi Han; Ying Han; Dai-ming Fan
Journal:  Dis Markers       Date:  2014-10-19       Impact factor: 3.434

Review 6.  Why Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?

Authors:  Antonio Molinaro; Hanns-Ulrich Marschall
Journal:  Curr Hepatol Rep       Date:  2017-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.